Left Menu
Development News Edition

WMSS 2020: Axens Solutions aims to achieve 20 pct biofuels, cites Harshit Agarwal

Devdiscourse News Desk | Delhi | Updated: 31-01-2020 13:12 IST | Created: 31-01-2020 13:12 IST
WMSS 2020: Axens Solutions aims to achieve 20 pct biofuels, cites Harshit Agarwal
Harshit Agarwal explained how Axens Solutions converts biomass into ethanol through fermentation. Image Credit: Devdiscourse News Desk

Indus Exposium organizes the second edition of the Waste Management Series of Summits between January 30 and 31, and Devdiscourse is the media partner of the event. Here you get the details of what Harshit Agarwal, Deputy Country Sales Manager, BU Process Licensing, Axens Solutions cited on the right utilization of biomass technology to ensure the right up-gradation in the future of transportation fuel.

While presenting Axens Solutions' innovative roles at the ongoing Waste Management Series of Summits (WMSS) 2020, Harshit Agarwal said that he is looking forward to the indicative target of achieving 20 percent blending of biofuels with fossil-based fuels by 2030. Now here are the two challenges that Agarwal had risen - growing waste and climatic change which really affect the process of biofuel production. He explained how Axens Solutions converts biomass into ethanol through fermentation, which not only helps waste collection but also contributes to the circular economy.

Agarwal also explained the futurol technology of his company that is backed by several industrial and financial partners. The production chain goes from biomass cultivation and transformation to the development and industrialization of fuels and petrochemical production processes.

Axens Solutions is a multi-national company that provides services for new and existing plants in the refining and petrochemical industries. These services range from consulting and feasibility studies to energy assessments and crude selection optimization.

Also Read: WMSS 2020 opens with discussions on how to strategize waste management system

Download The Devdiscourse News App for Latest News.



All party meeting - Blocking dialogue not culture of Bengal, Mamata needs to speak up

If that happens, history will record it as the dark age of Bengal....

Diya Jalao for COVID 19: How Modi put Power Grids and power warriors at risk?

While Prime Minister Narendra Modis staunch supporters are busy in search of hidden science behind the sudden announcement of 9minutes9pm campaign but his ignorance of the actual science has put the nation in another danger. The scientists ...

'Diya jalao' for COVID 19: Modi needs to practice his teachings and control fake news on social media

In his video message to the nation on Friday the Prime Minister talks about peoples collective power to win the invincible. However, he has made no concreate efforts to win over the confidence and represent the collective power of the polit...


Latest News

Dhoni owns Malinga in IPL battles between CSK and MI: Styris

Former New Zealand all-rounder Scott Styris believes the IPL rivalry between Chennai Super Kings and Mumbai Indians pits the games best finisher, M S Dhoni, against the best death bowler, Lasith Malinga, in which the former India captain ow...

Pak cancels Baisakhi celebrations at Gurdwara Punja Sahib amid COVID-19 crisis

Pakistani authorities have cancelled the Baisakhi celebrations at Gurdwara Punja Sahib in Punjab province from April 14, in which around 3,000 Sikhs from India were to participate, due to the coronavirus pandemic in the country, a media rep...

COVID-19 death toll rises to 109, number of cases to 4,067: Health Ministry

The death toll due to novel coronavirus rose to 109 and the number of cases in the country climbed to 4,067 on Monday, according to the Union Health Ministry. While the number of active COVID-19 cases stands at 3,666, as many as 291 people ...

Lupin launches generic drug used for prevention of organ rejection in kidney transplant in US

Drug firm Lupin on Monday said it has launched generic Mycophenolic acid delayed-release tablets, which is used to prevent organ rejection in patients receiving kidney transplants in the US market. The company has launched the tablets in th...

Give Feedback